To be a world leader in blood analysis using artificial intelligence for early detection of cancers and other diseases
EVERY DAY COUNTS
For health services
ClinSpec Dx™ Triage ID
a revolutionary blood serum test using
Fast, inexpensive and easy to undertake, the ClinSpec Dx™ Triage ID system uses revolutionary technology to provide accurate results in minutes.
How does it work?
Minute volumes of human serum.
Simple sample preparation.
Accurate results in less than 10 minutes.
ClinSpec Dx™ has significant potential in treatment monitoring, differentiation of pseudo-progression from actual disease progression, and screening for recurrence.
Same-day detection of brain cancer with high sensitivity and specificity, enabling fast referral of patients for full diagnosis and treatment.
Cost saving as a triage tool for brain cancer by reducing unnecessary brain scans.
Strong potential as a pan-cancer test, and for detection of infectious disease.
Potential to replace invasive biopsies in high-risk cases, saving valluable time and hospitalisation costs.
Ability to indicate the type and severity of tumours, and to trace metastatic cancer back to its origin.
Earlier diagnosis and classification of patients leads to significantly improved treatment options and patient outcomes.
Safe, reagent-free, non-destructive analysis requiring no specialist training and minimal sample preparation.
Potential as a companion diagnostic for precision medicine.
With an initial focus on detecting and grading brain cancer, the ClinSpec Dx™ Triage ID test can be adapted to identify and diagnose other chronic and infectious diseases, with patent filings currently underway for further clinical applications